REPORT ID 2885

Global Breast Cancer Monoclonal Antibodies Market Research Report 2017

Publish Date
12-Dec-17
Pages
129
Format
Electronic (PDF)

In this report, the global Breast Cancer Monoclonal Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Breast Cancer Monoclonal Antibodies in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Breast Cancer Monoclonal Antibodies market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    F. Hoffmann-La Roche
    Amgen
    Mylan
    Pfizer
    Merck
    Novartis
    GlaxoSmithKline
    AstraZeneca
    Eisai
    Boehringer Ingelheim
    Puma Biotechnology
    Teva Pharmaceuticals
    Sun Pharmaceutical Industries
    Watson Pharmaceuticals
    Allergan
    Synta Pharmaceuticals
    Chugai Pharmaceutical
    Daiichi Sankyo
    Array BioPharma
    Biocad
    Seattle Genetics
    Galena Biopharma
    Eddingpharm
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Naked mAbs
    Conjugated mAbs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals
    Clinics
    Retail Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Breast Cancer Monoclonal Antibodies Market Research Report 2017
1 Breast Cancer Monoclonal Antibodies Market Overview
    1.1 Product Overview and Scope of Breast Cancer Monoclonal Antibodies
    1.2 Breast Cancer Monoclonal Antibodies Segment by Type (Product Category)
        1.2.1 Global Breast Cancer Monoclonal Antibodies Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Breast Cancer Monoclonal Antibodies Production Market Share by Type (Product Category) in 2016
        1.2.3 Naked mAbs
        1.2.4 Conjugated mAbs
    1.3 Global Breast Cancer Monoclonal Antibodies Segment by Application
        1.3.1 Breast Cancer Monoclonal Antibodies Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Retail Pharmacies
    1.4 Global Breast Cancer Monoclonal Antibodies Market by Region (2012-2022)
        1.4.1 Global Breast Cancer Monoclonal Antibodies Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Breast Cancer Monoclonal Antibodies (2012-2022)
        1.5.1 Global Breast Cancer Monoclonal Antibodies Revenue Status and Outlook (2012-2022)
        1.5.2 Global Breast Cancer Monoclonal Antibodies Capacity, Production Status and Outlook (2012-2022)

2 Global Breast Cancer Monoclonal Antibodies Market Competition by Manufacturers
    2.1 Global Breast Cancer Monoclonal Antibodies Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Breast Cancer Monoclonal Antibodies Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Breast Cancer Monoclonal Antibodies Production and Share by Manufacturers (2012-2017)
    2.2 Global Breast Cancer Monoclonal Antibodies Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Breast Cancer Monoclonal Antibodies Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Breast Cancer Monoclonal Antibodies Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Breast Cancer Monoclonal Antibodies Market Competitive Situation and Trends
        2.5.1 Breast Cancer Monoclonal Antibodies Market Concentration Rate
        2.5.2 Breast Cancer Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Breast Cancer Monoclonal Antibodies Capacity and Market Share by Region (2012-2017)
    3.2 Global Breast Cancer Monoclonal Antibodies Production and Market Share by Region (2012-2017)
    3.3 Global Breast Cancer Monoclonal Antibodies Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Breast Cancer Monoclonal Antibodies Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Breast Cancer Monoclonal Antibodies Consumption by Region (2012-2017)
    4.2 North America Breast Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Breast Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
    4.4 China Breast Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Breast Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Breast Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)
    4.7 India Breast Cancer Monoclonal Antibodies Production, Consumption, Export, Import (2012-2017)

5 Global Breast Cancer Monoclonal Antibodies Production, Revenue (Value), Price Trend by Type
    5.1 Global Breast Cancer Monoclonal Antibodies Production and Market Share by Type (2012-2017)
    5.2 Global Breast Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
    5.3 Global Breast Cancer Monoclonal Antibodies Price by Type (2012-2017)
    5.4 Global Breast Cancer Monoclonal Antibodies Production Growth by Type (2012-2017)

6 Global Breast Cancer Monoclonal Antibodies Market Analysis by Application
    6.1 Global Breast Cancer Monoclonal Antibodies Consumption and Market Share by Application (2012-2017)
    6.2 Global Breast Cancer Monoclonal Antibodies Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Breast Cancer Monoclonal Antibodies Manufacturers Profiles/Analysis
    7.1 F. Hoffmann-La Roche
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 F. Hoffmann-La Roche Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Amgen
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Amgen Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Mylan
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Mylan Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Pfizer
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Pfizer Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Merck
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Merck Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Novartis
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Novartis Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 GlaxoSmithKline
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 GlaxoSmithKline Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 AstraZeneca
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 AstraZeneca Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Eisai
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Eisai Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Boehringer Ingelheim
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Breast Cancer Monoclonal Antibodies Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Puma Biotechnology
    7.12 Teva Pharmaceuticals
    7.13 Sun Pharmaceutical Industries
    7.14 Watson Pharmaceuticals
    7.15 Allergan
    7.16 Synta Pharmaceuticals
    7.17 Chugai Pharmaceutical
    7.18 Daiichi Sankyo
    7.19 Array BioPharma
    7.20 Biocad
    7.21 Seattle Genetics
    7.22 Galena Biopharma
    7.23 Eddingpharm

8 Breast Cancer Monoclonal Antibodies Manufacturing Cost Analysis
    8.1 Breast Cancer Monoclonal Antibodies Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Breast Cancer Monoclonal Antibodies

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Breast Cancer Monoclonal Antibodies Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Breast Cancer Monoclonal Antibodies Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Breast Cancer Monoclonal Antibodies Market Forecast (2017-2022)
    12.1 Global Breast Cancer Monoclonal Antibodies Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Breast Cancer Monoclonal Antibodies Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Breast Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Breast Cancer Monoclonal Antibodies Price and Trend Forecast (2017-2022)
    12.2 Global Breast Cancer Monoclonal Antibodies Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Breast Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Breast Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Breast Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Breast Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Breast Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Breast Cancer Monoclonal Antibodies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Breast Cancer Monoclonal Antibodies Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Breast Cancer Monoclonal Antibodies Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer